Navigation Links
New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
Date:12/13/2010

ions will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.Media Contacts: Dana BanksMasimo Corporation(949) 297-7348dbanks@masimo.comMasimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, Pulse CO-Oximetry, Pulse CO-Oximeter, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57, Rad-8, Rad-5, Pronto-7, Pronto, Patient SafetyNet, and SEDLine  are trademarks or registered trademarks of Masimo Corporation.


'/>"/>
SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. First Patient Enrolled in Multi-Center Clinical Trial of the CorMatrix® ECM® for Pericardial Closure to Reduce the Incidence of New Onset Postoperative Atrial Fibrillation
2. Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
3. EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
4. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
5. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
6. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
7. Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial
8. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
9. Sunridge Middle East Distributor to Begin Clinical Trials Necessary for Reimbursement
10. InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScan™ Coronary Imaging System
11. HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
(Date:5/22/2015)... , May 22, 2015 The Assistance ... Program. This program provides financial assistance for copay to ... pleased to announce the addition of the Melanoma Copay ... Mark McGreevy , executive director. "With each additional ... vision of a world where no one is denied ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... NORTH WALES, Pa., Aug. 18 AirPal ®, ... and positioning technology, has announced the expansion of its ... positioning functionality. "This announcement marks the launch ... Positioning™ systems," said Jim Weedling, President AirPal, Inc.  "Among ...
... LAUDERDALE, Fla., Aug. 18 After a lengthy ... of power mobility products and services, has selected ... to help strengthen and broaden the company,s brand ... Advertising and Daggerwing, Omnicom,s team will include Javelin ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2Omnicom Adds National Healthcare Giant to Client Roster 2Omnicom Adds National Healthcare Giant to Client Roster 3
(Date:5/26/2015)... Many sexy cocktail dresses inspired by celebrities have ... Now, TheCelebrityDresses.com is offering great discounts on all ... The company aims to help ladies from all ... on valuable, trendy formal outfits. , TheCelebrityDresses.com is ... occasion dresses. Their dresses are popular among both ...
(Date:5/26/2015)... U.S. Food and Drug Administration (FDA) regulations ... extensive and can be difficult to understand. Registrar ... companies comply with FDA regulations, compiled a list of ... requirements. , 1. Start researching early. Marketing ... a lengthy process depending on the classification of the ...
(Date:5/26/2015)... Carl W. Berk, M.D. and his fellow board ... have launched a Balloon Sinuplasty website to inform potential ... the benefits of Balloon Sinuplasty. , The website includes ... someone is a good candidate for Balloon Sinuplasty. The ... can contribute to chronic nasal congestion. If the user ...
(Date:5/25/2015)... (PRWEB) May 26, 2015 The ... Hooker as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in dentistry. NAPW is ... boasting more than 700,000 members and over 200 operating ... into this exceptional group of professional women,” said NAPW ...
(Date:5/25/2015)... 25, 2015 World Patent Marketing, a ... the Hidee-Hose, an undergarment patent that allays women’s fears ... Women's Hosiery industry forecasts the market to reach $20.3 ... Creative Director of World Patent Marketing , "The ... ahead and is expected to maintain its lead. The ...
Breaking Medicine News(10 mins):Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3
... such as broccoli, Brussel sprouts, cauliflower and green cabbage ... of cancer . But, researchers have now warned that ... properties. ,Brassica vegetables have a high concentration ... cancer preventive substances known as isothiocyanates. ...
... heed of, by bosses. The study shows that feelings of ... consequences, like a heart attack. ,The study ... published in the Journal of Epidemiology and Community Health tracked ... for almost 11 years. ,The researchers found that ...
... percent of U.S. adults may have some form of ... about 2.4 percent with a "sub-threshold" condition, according ... General Psychiatry. ,Individuals with bipolar disorder tend ... characterized by impulsive behavior and an increased activity leveland ...
... American research, the most effective weight-loss diet for any person ... author David Ludwig, director of the Optimal Weight for Life ... shows that one diet doesn't necessarily fit all', also notes ... their weight in their midsection lost a lot more ...
... scientists at the Georgia Institute of Technology and the Ovarian ... to be essential in helping chemotherapy kill cancer cells, may ... 70 percent of subjects whose tumors had mutations in the ... normal p53 displayed only a 30 percent survival rate. ...
... new study has shown that cigarette smoking is more strongly ... ,The study, published in the Journal of ... and neck cancers among non-drinkers was due to smoking. ... Agency for Cancer Research in Lyon, the researchers examined head ...
Cached Medicine News:Health News:Boiling Makes Broccoli to Loses Its Anticancer Properties 2Health News:Feelings Of Injustice At Work Can Lead To A Heart Attack 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 3Health News:Check Your Physiology Before You Choose A Diet 2Health News:Gene Thought to Help Kill Cancer Cells may Actually Help Them Thrive 2
... 10 mm applier contains 20 titanium clips in ... clips in the L size. The appliers are ... sized Auto Suture trocar sleeves, or larger sized ... After introduction of the ENDO CLIP clip applier ...
... Multi-Use Reposable Clip Applier ... disposables with the economics ... superior instrument balance and ... cartridges. The multi-use Reposable ...
Pilling-Weck, medium-large clip size, 10mm, rotatable take apart...
Pilling-Weck, small clip size, 10mm, rotatable take apart...
Medicine Products: